Ángel
García Alonso
Imperial College London
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de Imperial College London (2)
2019
-
Proteomic studies reveal disrupted in schizophrenia 1 as a player in both neurodevelopment and synaptic function
International Journal of Molecular Sciences, Vol. 20, Núm. 1
2014
-
Phase II trial of cetuximab and conformal radiotherapy only in locally advanced pancreatic cancer with concurrent tissue sampling feasibility study
Translational Oncology, Vol. 7, Núm. 1, pp. 55-64